Meta-analysis of trials comparing oral anticoagulation and aspirin versus dual antiplatelet therapy after coronary stenting: Clues for the management of patients with an indication for long-term anticoagulation undergoing coronary stenting

Cardiology

Volumn 104, Issue 2, 2005, Pages 101-106

  Rubboli, Andrea ^a   Milandri, Milena ^a   Castelvetri, Cristina ^a   Cosmi, Benilde ^b  

^a MAGGIORE HOSPITAL   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Antiplatelets; Aspirin; Coronary angioplasty; Coronary stent; Oral anticoagulants; Ticlopidine

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; HEPARIN; PHENPROCOUMON; TICLOPIDINE; WARFARIN;

ANTICOAGULATION; BLEEDING; CARDIOVASCULAR RISK; CLINICAL TRIAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CORONARY STENT; DEATH; HEART DISEASE; HEART INFARCTION; HUMAN; LONG TERM CARE; META ANALYSIS; PATIENT CARE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVASCULARIZATION; REVIEW; RISK ASSESSMENT; STATISTICAL ANALYSIS; THROMBOSIS; TREATMENT INDICATION; VASCULAR DISEASE;

ADMINISTRATION, ORAL; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTICOAGULANTS; ASPIRIN; CORONARY STENOSIS; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HUMANS; LONG-TERM CARE; MULTICENTER STUDIES; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PLATELET AGGREGATION INHIBITORS; RANDOMIZED CONTROLLED TRIALS; STENTS; TICLOPIDINE; TREATMENT OUTCOME;

EID: 23944450574     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086918     Document Type: Review

References (20)

1. Schömig A, Neumann FJ, Kastrati A, Schuhlen H, Blasini R, Hadamitzky M, Walter H, Zitzmann-Roth EM, Richardt G, Alt E, Schmitt C, Ulm K: A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996;334:1084-1089.
2. Leon MB, Baim DS, Popma JJ, Gordon PC, Cutlip DE, Ho KK, Giambartolomei A, Diver DJ, Lasorda DM, Williams DO, Pocock SJ, Kuntz RE: A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. N Engl J Med 1998;339:1665-1671.
3. Bertrand ME, Legrand V, Boland J, Fleck E, Bonnier J, Emmanuelson H, Vrolix M, Missault L, Chierchia S, Casaccia M, Niccoli L, Oto A, White C, Webb-Peploe M, Van Belle E, McFadden EP: Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The Full Anticoagulation Versus Aspirin and Ticlopidine (FANTASTIC) Study. Circulation 1996;98:1597-1603.
4. Urban P, Macaya C, Rupprecht HJ, Kiemeneij F, Emanuelsson H, Fontanelli A, Pieper M, Wesseling T, Sagnard L: Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients. The Multicenter Aspirin and Ticlopidine Trial after Intracoronary Stenting (MATTIS). Circulation 1998;98:2126-2132.
5. Cosmi B, Rubboli A, Castelvetri C, Milandri M: Ticlopidine versus oral anticoagulation after coronary stenting (Cochrane review). Cochrane Database Syst Rev 2001;4:CD002133.
6. Rubboli A, Colletta M, Sangiorgio P, Di Pasquale G: Antithrombotic treatment after coronary artery stenting in patients on chronic oral anticoagulation: an international survey of current clinical practice. Ital Heart J 2004;5:851-856.
7. Orford JL, Fasseas P, Melby S, Burger K, Steinhubl SR, Holmes DR, Berger PB: Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation. Am Heart J 2004;147:463-467.
8. Rubboli A, Colletta M, Sangiorgio P, Di Pasquale G: Antithrombotic strategies in patients with an indication for long-term anticoagulation undergoing coronary artery stenting: safety and efficacy data from a single center. Ital Heart J 2004;5:919-925.
9. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ: Assessing the quality of reports of randomized clinical trias: is blinding necessary? Control Clin Trials 1996;17:1-12.
10. Schulz KF, Chalmers I, Hayes RJ, Altman DG: Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408-412.
11. Cohen J: A coefficient of agreement for nominal scales. Educ Psychol Meas 1960;20:37-46.
12. Landis RJ, Koch GG: The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174.
13. Stein PD, Alpert JS, Bussey HI, Dalen JE, Turpie AG: Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest 2001;119:220S-227S.
14. Hull RD, Delmore T, Genton E, Hirsh J, Gent M, Sackett D, McLoughlin D, Armstrong P: Warfarin sodium versus low-dose heparin for the long-term treatment of venous thrombosis. N Engl J Med 1979;301:855-858.
15. Hirsh J, Lee A: How we diagnose and treat deep vein thrombosis. Blood 2002;99:3102-3110.
16. Hyers TM, Agnelli G, Hull RD, Morris TA, Samama M, Tapson V, Weg JG: Antithrombotic therapy for venous thromboembolic disease. Chest 2001;119:176S-193S.
17. Albers GW, Dalen JE, Laupacis A, Manning WJ, Petersen P, Singer DE: Antithrombotic therapy in atrial fibrillation. Chest 2001;119:194S-206S.
18. Prandoni P, Lensing AW, Piccioli A, Bernardi E, Simioni P, Girolami B, Marchiori A, Sabbion P, Prins MH, Noventa F, Girolami A: Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 2002;100:3484-3488.
19. Nasser T, Mohleri EI, Wilensky R, Hathaway D: Peripheral vascular complications following coronary interventional procedures. Clin Cardiol 1995;18:609-614.
20. Waksman R, King SB 3rd, Douglas JS, Shen Y, Ewing H, Mueller L, Ghazzal ZM, Weintraub WS: Predictors of groin complications after balloon and new device coronary intervention. Am J Cardiol 1995;75:886-889.